Valuation check: VCRE's profit margin is -20773.26%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
Vicore Pharma Holding AB (VCRE) currently reports a profit margin of -20773.26% as of September 2026. That compares with -7753.25% in the prior-year period — down 167.9% year over year. That is below the Healthcare sector average of 17.63%. Use the charts on this page to explore Vicore Pharma Holding AB's profit margin history and peer comparisons.
Vicore Pharma Holding AB's profit margin decreased from -7753.25% to -20773.26% — a 167.9% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Vicore Pharma Holding AB's profit margin of -20773.26% is lower than the Healthcare sector average of 17.63%. That is roughly 117939.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Vicore Pharma Holding AB's current -20773.26% should be judged against Healthcare norms (sector average: 17.63%) and against VCRE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -20773.26%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 17.63%. From there, open related valuation or income-statement pages for Vicore Pharma Holding AB, and consider following VCRE for alerts when major investors trade the stock.